
Extra cancer scans for women with dense breasts could save 700 lives a year
Hundreds of lives could be saved every year with extra cancer checks for women with very dense breasts, a study suggests.
Millions of women undergo breast screening, but regular mammograms can be less effective at spotting cancer in the 10% with very dense breasts, as the tissue can hide tumours on X-rays. This is because very dense breasts look whiter on scans, making it harder to detect early-stage disease, which also appears white.
Offering this group of women enhanced scans could find 3,500 more cases of cancer and save 700 lives a year in the UK, researchers from the University of Cambridge said. Their findings were published in the Lancet.
The study's lead author, Prof Fiona Gilbert, said: 'Getting a cancer diagnosis early makes a huge difference for patients in terms of their treatment and outlook. We need to change our national screening programme so we can make sure more cancers are diagnosed early, giving many more women a much better chance of survival.'
She added: 'In addition to the relevance for the UK's breast cancer screening programme, this study has global implications for all countries where screening is undertaken for women with dense breast tissue.'
The study involved 9,361 women in the UK who had dense breasts and had received a negative (no cancer) mammogram result. When additional scanning methods were trialled, an extra 85 cancers were found.
Two methods examined were contrast-enhanced mammography (CEM), in which dye is used to make blood vessels more visible, and abbreviated magnetic resonance imaging (Ab-MRI), which is faster than a regular MRI.
Researchers said adding either method to existing screening could detect 3,500 more cancers a year in the UK. With screening reducing mortality for about 20% of cancers detected, this could mean an extra 700 lives saved a year, the Cambridge team said.
A third scanning method used in the trial – automated breast ultrasound (Abus) – also picked up cancers but was much less effective than CEM and Ab-MRI.
CEM detected 19 cancers for every 1,000 women scanned, Ab-MRI found 17 and Abus found four. With mammograms already detecting about eight cases of cancer per 1,000 women with dense breasts, additional scans could more than treble breast cancer detection, the researchers said.
The trial was funded by Cancer Research UK (CRUK) with support from the National Institute for Health and Care Research Cambridge Biomedical Research Centre.
Although the trial showed the scans could detect additional small cancers, which would probably save lives, further research is needed to confirm whether they could reduce the number of deaths, in order to establish the risk of overdiagnosis and to estimate the cost-benefit ratio of offering extra scans.
'More research is needed to fully understand the effectiveness of these techniques, but these results are encouraging,' said Dr David Crosby, the head of prevention and early detection at CRUK.
Dr Kotryna Temcinaite, the head of research communications and engagement at Breast Cancer Now, said: 'The UK National Screening Committee now needs to consider this research as part of their current review to determine whether women with very dense breasts should be offered additional imaging during their routine screening.'
She added: 'Routine breast screening is the most likely route to finding breast cancer early, when treatment is most likely to be successful. While we know that the current process can be less effective in detecting cancers in dense breasts, we still encourage all women to attend mammogram screening when invited.'
The Department for Health and Social Care said research into enhanced scans for women with dense breasts was being carried out as part of the NHS breast screening programme. 'The UK National Screening Committee is reviewing this evidence as it becomes available,' a spokesperson said.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Daily Mail
2 hours ago
- Daily Mail
EXCLUSIVE How women blighted by cruel back pain may actually have hidden arthritis - as doctors reveal there's a simple drug cure that can end the agony. Special report by ETHAN ENNALS
Clair Evans believes her back pain began during her teens – but she has lived with the debilitating problem for so long that she struggles to remember a time when she wasn't in agony. The 47-year-old from Doncaster says her lower back became extremely stiff, and often the pain would radiate down into her legs. She also found that certain movements triggered excruciating spasms.


Daily Mail
2 hours ago
- Daily Mail
STEPHEN POLLARD: Labour's created an atmosphere where the hard working middle class are now fair game for bigotry
That an eight-year-old can be refused healthcare on the NHS because of the school he attends is deeply troubling. It shows that the service once described by Margaret Thatcher 's Chancellor Nigel Lawson as 'the closest thing the English people have to a religion,' has become a battleground for class war where children seeking treatment are seen as the enemy of the proletariat. That includes my children. I am lucky enough to be able to pay for them to attend private schools. I pay the fees on top of my taxes, of course. Now it seems the NHS regards my kids as non-citizens to be shunned.


Daily Mail
2 hours ago
- Daily Mail
One of NHS's biggest AI projects is halted after fears it used health data of 57 MILLION people without proper permissions
NHS England has paused a ground-breaking AI project designed to predict an individual's risk of health conditions after concerns were raised data from 57 million people was being used without the right permissions. Foresight, which uses Meta 's open-source AI model, Llama 2, was being tested by researchers at University College London and King's College London as part of a national pilot scheme exploring how AI could be used to tailor healthcare plans for patients based on their medical history. But the brakes were applied to the pioneering scheme after experts warned even anonymised records could contain enough information to identify individuals, The Observer reported. A joint IT committee between the British Medical Association (BMA) and the Royal College of General Practitioners (RCGP) also said it they had not been made aware that data collected for research into Covid was now being used to train the AI model. The bodies have also accused the research consortium, led by Health Data Research UK, of failing to consult an advisory body of doctors before feeding the health data of tens of millions of patients into Foresight. Both BMA and RGCP have asked NHS England to refer itself to the Information Commissioner over the matter. Professor Kamila Hawthorne, chair of RGCP, said the issue was one of 'fostering patient trust' that their data was not being used 'beyond what they've given permission for.' She said: 'As data controllers, GPs take the management of their patients' medical data very seriously, and we want to be sure data isn't being used beyond its scope, in this case to train an AI programme. 'We have raised our concerns with NHS England, through the Joint GP IT Committee, and the committee has called for a pause on data processing in this way while further investigation takes place, and for NHS England to refer itself to the Information Commissioner. 'Patients need to be able to trust their personal medical data is not being used beyond what they've given permission for, and that GPs and the NHS will protect their right to data privacy. 'If we can't foster this patient trust, then any advancements made in AI – which has potential to benefit patient care and alleviate GP workload – will be undermined. 'We hope to hear more from NHS England in due course, providing definitive and transparent answers to inform our next steps.' Katie Bramall, BMA England GP committee chair, said: 'For GPs, our focus is always on maintaining our patients' trust in how their confidential data is handled. 'We were not aware that GP data, collected for Covid-19 research, was being used to train an AI model, Foresight. 'As such, we are unclear as to whether the correct processes were followed to ensure that data was shared in line with patients' expectations and established governance processes. 'We have raised our concerns with NHS England through the joint GP IT committee and appreciate their verbal commitment to improve on these processes going forward. 'The committee has asked NHS England to refer itself to the Information Commissioner so the full circumstances can be understood, and to pause ongoing processing of data in this model, as a precaution, while the facts can be established.' 'Patients shouldn't have to worry that what they tell their GP will get fed to AI models without the full range of safeguards in place to dictate how that data is shared.' An NHS spokesperson confirmed that development of the Foresight model had been paused for the time being.